GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer

作者全名："Shi, Yan-long; Liu, Ming-bo; Wu, Hong-ting; Han, Ye; He, Xuan"

作者地址："[Shi, Yan-long] Chongqing Med Univ, Women & Childrens Hosp, Dept Med, Chongqing, Peoples R China; [Liu, Ming-bo; Wu, Hong-ting; Han, Ye] Chongqing Med Univ, Women & Childrens Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China; [He, Xuan] Army Med Univ, Daping Hosp, Canc Ctr, Chongqing, Peoples R China"

通信作者："He, X (通讯作者)，Army Med Univ, Daping Hosp, Canc Ctr, Chongqing, Peoples R China."

来源：DISEASE MARKERS

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:000830778700003

JCR分区：Q3

影响因子：3.464

年份：2022

卷号：2022

期号：　

开始页：　

结束页：　

文献类型：Article

关键词：　

摘要："Cervical cancer (CC) is the fourth most commonly diagnosed cancer in women worldwide. The prognosis of CC patients remains poor. The objective of our study was to explore the potential of glycolipid transfer protein (GLTP) in predicting the prognosis of CC and patients' response to immunotherapy. The expression of GLTP was determined using TCGA and GEO datasets. The prognostic value of GLTP in CC patients was analyzed using Kaplan-Meier analysis and multivariate analysis. The relationships between BTBD10 and immunological checkpoints, immune checkpoint genes, and ferroptosis-related genes were analyzed to explore the impact of GLTP on CC immunotherapy. According to the dysregulated expressions of BTBD10, the IC50 distribution of various targeted medicines was studied. In this study, we found that GLTP expression was distinctly upregulated in CC specimens. However, Kaplan-Meier assays showed that CC patients with low GLTP expressions tended to exhibit a shorter overall survival. Importantly, multivariate assays revealed that GLTP expression was an independent prognostic factor for CC patients. Moreover, we observed that GLTP expression was related to CD4+ T cells, macrophages, and dendritic cells (DCs). Meanwhile, GLTP expressions were associated with those of immune checkpoints, ferroptosis-related genes, and m6A-related genes. The IC50 of Cisplatin, Docetaxel, and Paclitaxel was lower in the high-GLTP-expressing group. Taken together, GLTP was expected to be a prognostic and immunotherapeutic marker for CC."

基金机构：　

基金资助正文：